Acute promyelocytic leukemia in a patient with multiple sclerosis following treatment with mitoxantrone
Author:
Publisher
Springer Science and Business Media LLC
Subject
Oncology,Cancer Research,Hematology
Link
http://www.nature.com/articles/2403417.pdf
Reference8 articles.
1. Beaumont M, Sanz M, Carli PM, Maloisel F, Thomas X, Detourmignies L et al. Therapy related acute promyelocytic leukemia. J Clin Oncol 2003; 21: 2123–2137.
2. Pedersen-Bjergaard J, Andersen MK, Christiansen DH, Nerlov C . Genetic pathways in therapy related myelodysplasia and acute myeloid leukemia. Blood 2002; 99: 1909–1912.
3. Andersen MK, Larson RA, Mauritzson N, Schnittger S, Jhanwar SC, Pedersen-Bjergaard J . Balanced chromosomal abnormalities inv(16) and t(15,17) in therapy related myelodysplastic syndromes and acute leukemia: report from an international workshop. Genes Chromosomes Cancer 2002; 33: 395–400.
4. Polman CH, Uitdehaag BM . New and emerging treatment options for multiple sclerosis. Lancet Neurol 2003; 2: 563–566.
5. Ghalie RG, Mauch E, Edan G, Hartung HP, Gonsette RE, Eisenmann S et al. A study of therapy related acute leukemia after mitoxantrone therapy for multiple sclerosis. Mult Scler 2002; 8: 441–445.
Cited by 33 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Exploring the potential of plating solution on the fabrication of ex-situ Bi film plated glassy carbon electrode for detection of mitoxantrone drug residue;Microchemical Journal;2024-10
2. Synergistic and complete reversal of the multidrug resistance of mitoxantrone hydrochloride by three-in-one multifunctional lipid-sodium glycocholate nanocarriers based on simultaneous BCRP and Bcl-2 inhibition;International Journal of Nanomedicine;2016-08
3. Nanostructured lipid–carrageenan hybrid carriers (NLCCs) for controlled delivery of mitoxantrone hydrochloride to enhance anticancer activity bypassing the BCRP-mediated efflux;Drug Development and Industrial Pharmacy;2016-02-16
4. Bioreductive activation of mitoxantrone by NADPH cytochrome P450 reductase does not change its apoptotic stimuli properties in regard to sensitive and multidrug resistant leukaemia HL60 cells;European Journal of Pharmacology;2013-12
5. Results from the 5-year, phase IV RENEW (Registry to Evaluate Novantrone Effects in Worsening Multiple Sclerosis) study;BMC Neurology;2013-07-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3